Diabetes technology was once regarded as largely confined to type 1 diabetes, but its role is now expanding across the diabetes spectrum, with CGM increasingly recognized as a tool that can aid management from diagnosis to any therapeutic stage. This session highlights the evolving use of diabetes technology in intermediate hyperglycemia (Prediabetes), type 2 diabetes, tech-naïve older adults, and pregnancy, and examines how automated insulin delivery in type 2 diabetes is advancing beyond meal-unannounced approaches toward fully closed-loop, “set-and-forget” systems. Together, these talks will provide a timely overview of the next wave of diabetes technology and its expanding role across the continuum of diabetes care.